|
|
||||||||
The Journal of Immunology, Vol 156, Issue 6 2095-2103, Copyright © 1996 by American Association of Immunologists
ARTICLES |
DD Taub, SM Turcovski-Corrales, ML Key, DL Longo and WJ Murphy
Clinical Services, Science Applications International Corporation- Frederick, MD 21702, USA.
While chemokines primarily promote chemotaxis, it is apparent that these cytokines also modulate a number of other biologic activities, including adhesion, degranulation, cytotoxicity, and enzyme release. We demonstrate here that the beta chemokines, recombinant human macrophage inflammatory protein-1 alpha and -1 beta, RANTES (regulated upon activation, normally T cell expressed and secreted), and macrophage chemotactic peptide-1, are capable of directly costimulating purified human T cell and human T cell clone proliferation and IL-2 production in the presence of anti-CD3 mAb, but not phorbol esters, in vitro. This costimulatory activity was dose and donor dependent and required the presence of free extracellular calcium as well as endogenously produced IL-2. Chemokine treatment of human T cells in vitro increased the level of cell surface CD25 and soluble CD25. In addition, these chemokines enhanced both Ag- and alloantigen-specific T cell and T cell clone proliferation. This activity was further augmented in the presence of the CD28 ligand, B7-1. Neutralization analyses using chemokine-specific Abs revealed that endogenously produced chemokines are important costimulatory mediators in human T cell activation. Together, these results suggest that chemokines not only play an important role in lymphocyte recruitment to inflammatory sites, but also participate in T cell activation.
This article has been cited by other articles:
![]() |
B. Lange-Sperandio, A. Trautmann, O. Eickelberg, A. Jayachandran, S. Oberle, F. Schmidutz, B. Rodenbeck, M. Homme, R. Horuk, and F. Schaefer Leukocytes Induce Epithelial to Mesenchymal Transition after Unilateral Ureteral Obstruction in Neonatal Mice Am. J. Pathol., September 1, 2007; 171(3): 861 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mummidi, L. M. Adams, S. E. VanCompernolle, M. Kalkonde, J. F. Camargo, H. Kulkarni, A. S. Bellinger, G. Bonello, H. Tagoh, S. S. Ahuja, et al. Production of Specific mRNA Transcripts, Usage of an Alternate Promoter, and Octamer-Binding Transcription Factors Influence the Surface Expression Levels of the HIV Coreceptor CCR5 on Primary T Cells J. Immunol., May 1, 2007; 178(9): 5668 - 5681. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jurewicz, D. H. McDermott, J. M. Sechler, K. Tinckam, A. Takakura, C. B. Carpenter, E. Milford, and R. Abdi Human T and Natural Killer Cells Possess a Functional Renin-Angiotensin System: Further Mechanisms of Angiotensin II-Induced Inflammation J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1093 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
M J Bugeja, D R Booth, B H Bennetts, R N. Heard, and G J Stewart An investigation of polymorphisms in the 4q13.3-21.1 CXC chemokine gene cluster for association with multiple sclerosis in Australians Multiple Sclerosis, November 1, 2006; 12(6): 710 - 722. [Abstract] [PDF] |
||||
![]() |
T. T. Murooka, M. M. Wong, R. Rahbar, B. Majchrzak-Kita, A. E. I. Proudfoot, and E. N. Fish CCL5-CCR5-mediated Apoptosis in T Cells: REQUIREMENT FOR GLYCOSAMINOGLYCAN BINDING AND CCL5 AGGREGATION J. Biol. Chem., September 1, 2006; 281(35): 25184 - 25194. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ancuta, P. Autissier, A. Wurcel, T. Zaman, D. Stone, and D. Gabuzda CD16+ Monocyte-Derived Macrophages Activate Resting T Cells for HIV Infection by Producing CCR3 and CCR4 Ligands J. Immunol., May 15, 2006; 176(10): 5760 - 5771. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tjarnlund, A. Rodriguez, P.-J. Cardona, E. Guirado, J. Ivanyi, M. Singh, M. Troye-Blomberg, and C. Fernandez Polymeric IgR knockout mice are more susceptible to mycobacterial infections in the respiratory tract than wild-type mice Int. Immunol., May 1, 2006; 18(5): 807 - 816. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Palaniappan, S. Singh, U. P. Singh, R. Singh, E. W. Ades, D. E. Briles, S. K. Hollingshead, W. Royal III, J. S. Sampson, J. K. Stiles, et al. CCL5 Modulates Pneumococcal Immunity and Carriage J. Immunol., February 15, 2006; 176(4): 2346 - 2356. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. O. Flores-Villanueva, J. A. Ruiz-Morales, C.-H. Song, L. M. Flores, E.-K. Jo, M. Montano, P. F. Barnes, M. Selman, and J. Granados A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis J. Exp. Med., December 19, 2005; 202(12): 1649 - 1658. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Stegelmann, M. Bastian, K. Swoboda, R. Bhat, V. Kiessler, A. M. Krensky, M. Roellinghoff, R. L. Modlin, and S. Stenger Coordinate Expression of CC Chemokine Ligand 5, Granulysin, and Perforin in CD8+ T Cells Provides a Host Defense Mechanism against Mycobacterium tuberculosis J. Immunol., December 1, 2005; 175(11): 7474 - 7483. [Abstract] [Full Text] [PDF] |
||||
![]() |
S L-F Pender, V Chance, C V Whiting, M Buckley, M Edwards, R Pettipher, and T T MacDonald Systemic administration of the chemokine macrophage inflammatory protein 1{alpha} exacerbates inflammatory bowel disease in a mouse model Gut, August 1, 2005; 54(8): 1114 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Roda, R. Parihar, and W. E. Carson III CpG-Containing Oligodeoxynucleotides Act through TLR9 to Enhance the NK Cell Cytokine Response to Antibody-Coated Tumor Cells J. Immunol., August 1, 2005; 175(3): 1619 - 1627. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Matsuyama, M. Watanabe, Y. Shirahama, K.-i. Oonakahara, I. Higashimoto, T. Yoshimura, M. Osame, and K. Arimura Activation of Discoidin Domain Receptor 1 on CD14-Positive Bronchoalveolar Lavage Fluid Cells Induces Chemokine Production in Idiopathic Pulmonary Fibrosis J. Immunol., May 15, 2005; 174(10): 6490 - 6498. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Amano, A. Bickerstaff, C. G. Orosz, A. C. Novick, H. Toma, and R. L. Fairchild Absence of Recipient CCR5 Promotes Early and Increased Allospecific Antibody Responses to Cardiac Allografts J. Immunol., May 15, 2005; 174(10): 6499 - 6508. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Y. Liu, M. Battaglia, S. H. Lee, Q.-H. Sun, R. H. Aster, and G. P. Visentin Platelet Factor 4 Differentially Modulates CD4+CD25+ (Regulatory) versus CD4+CD25- (Nonregulatory) T Cells J. Immunol., March 1, 2005; 174(5): 2680 - 2686. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Elhofy, J. Wang, M. Tani, B. T. Fife, K. J. Kennedy, J. Bennett, D. Huang, R. M. Ransohoff, and W. J. Karpus Transgenic expression of CCL2 in the central nervous system prevents experimental autoimmune encephalomyelitis J. Leukoc. Biol., February 1, 2005; 77(2): 229 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Skwor, H. Cho, C. Cassidy, T. Yoshimura, and D. N. McMurray Recombinant guinea pig CCL5 (RANTES) differentially modulates cytokine production in alveolar and peritoneal macrophages J. Leukoc. Biol., December 1, 2004; 76(6): 1229 - 1239. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. P. Singh, S. Singh, P. N. Boyaka, J. R. McGhee, and J. W. Lillard Jr Granulocyte chemotactic protein-2 mediates adaptive immunity in part through IL-8R{beta} interactions J. Leukoc. Biol., December 1, 2004; 76(6): 1240 - 1247. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Guerassimov, Y. Hoshino, Y. Takubo, A. Turcotte, M. Yamamoto, H. Ghezzo, A. Triantafillopoulos, K. Whittaker, J. R. Hoidal, and M. G. Cosio The Development of Emphysema in Cigarette Smoke-exposed Mice Is Strain Dependent Am. J. Respir. Crit. Care Med., November 1, 2004; 170(9): 974 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Whiting, G. Hsieh, J. J. Yun, A. Banerji, W. Yao, M. C. Fishbein, J. Belperio, R. M. Strieter, B. Bonavida, and A. Ardehali Chemokine Monokine Induced by IFN-{gamma}/CXC Chemokine Ligand 9 Stimulates T Lymphocyte Proliferation and Effector Cytokine Production J. Immunol., June 15, 2004; 172(12): 7417 - 7424. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Yun, D. Whiting, M. P. Fischbein, A. Banerji, Y. Irie, D. Stein, M. C. Fishbein, A. E.I. Proudfoot, H. Laks, J. A. Berliner, et al. Combined Blockade of the Chemokine Receptors CCR1 and CCR5 Attenuates Chronic Rejection Circulation, February 24, 2004; 109(7): 932 - 937. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. W. Wright, G. S. Pryhuber, P. R. Chess, Z. Wang, R. H. Notter, and F. Gigliotti TNF Receptor Signaling Contributes to Chemokine Secretion, Inflammation, and Respiratory Deficits during Pneumocystis Pneumonia J. Immunol., February 15, 2004; 172(4): 2511 - 2521. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. X. Zhong, W. A. Kuziel, E. G. Pamer, and N. V. Serbina Chemokine Receptor 5 Is Dispensable for Innate and Adaptive Immune Responses to Listeria monocytogenes Infection Infect. Immun., February 1, 2004; 72(2): 1057 - 1064. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Manes, E. Mira, R. Colomer, S. Montero, L. M. Real, C. Gomez-Mouton, S. Jimenez-Baranda, A. Garzon, R. A. Lacalle, K. Harshman, et al. CCR5 Expression Influences the Progression of Human Breast Cancer in a p53-dependent Manner J. Exp. Med., November 3, 2003; 198(9): 1381 - 1389. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fantuzzi, F. Belardelli, and S. Gessani Monocyte/macrophage-derived CC chemokines and their modulation by HIV-1 and cytokines: A complex network of interactions influencing viral replication and AIDS pathogenesis J. Leukoc. Biol., November 1, 2003; 74(5): 719 - 725. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. DePaolo, B. J. Rollins, W. Kuziel, and W. J. Karpus CC Chemokine Ligand 2 and Its Receptor Regulate Mucosal Production of IL-12 and TGF-{beta} in High Dose Oral Tolerance J. Immunol., October 1, 2003; 171(7): 3560 - 3567. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chaisavaneeyakorn, J. M. Moore, L. Mirel, C. Othoro, J. Otieno, S. C. Chaiyaroj, Y. P. Shi, B. L. Nahlen, A. A. Lal, and V. Udhayakumar Levels of Macrophage Inflammatory Protein 1{alpha} (MIP-1{alpha}) and MIP-1{beta} in Intervillous Blood Plasma Samples from Women with Placental Malaria and Human Immunodeficiency Virus Infection Clin. Vaccine Immunol., July 1, 2003; 10(4): 631 - 636. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Panoskaltsis-Mortari, J. R. Hermanson, E. Taras, O. D. Wangensteen, J. S. Serody, and B. R. Blazar Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1alpha (CCL3) after allogeneic BMT in mice Blood, May 1, 2003; 101(9): 3714 - 3721. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Huang, M. Tani, J. Wang, Y. Han, T. T. He, J. Weaver, I. F. Charo, V. K. Tuohy, B. J. Rollins, and R. M. Ransohoff Pertussis Toxin-Induced Reversible Encephalopathy Dependent on Monocyte Chemoattractant Protein-1 Overexpression in Mice J. Neurosci., December 15, 2002; 22(24): 10633 - 10642. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fleischer, E. Grage-Griebenow, B. Kasper, H. Heine, M. Ernst, E. Brandt, H.-D. Flad, and F. Petersen Platelet Factor 4 Inhibits Proliferation and Cytokine Release of Activated Human T Cells J. Immunol., July 15, 2002; 169(2): 770 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Dorner, A. Scheffold, M. S. Rolph, M. B. Huser, S. H. E. Kaufmann, A. Radbruch, I. E. A. Flesch, and R. A. Kroczek MIP-1alpha , MIP-1beta , RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines PNAS, April 30, 2002; 99(9): 6181 - 6186. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-o. Lee, C. J. Cooper, J.-h. Choi, Z. Alnadjim, and T. A. Barrett The State of CD4+ T Cell Activation Is a Major Factor for Determining the Kinetics and Location of T Cell Responses to Oral Antigen J. Immunol., April 15, 2002; 168(8): 3833 - 3838. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Saukkonen, B. Bazydlo, M. Thomas, R. M. Strieter, J. Keane, and H. Kornfeld {beta}-Chemokines Are Induced by Mycobacterium tuberculosis and Inhibit Its Growth Infect. Immun., April 1, 2002; 70(4): 1684 - 1693. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sabroe, C.M. Lloyd, M.K.B. Whyte, S.K. Dower, T.J. Williams, and J.E. Pease Chemokines, innate and adaptive immunity, and respiratory disease Eur. Respir. J., February 1, 2002; 19(2): 350 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nanki, K. Nagasaka, K. Hayashida, Y. Saita, and N. Miyasaka Chemokines Regulate IL-6 and IL-8 Production by Fibroblast-Like Synoviocytes from Patients with Rheumatoid Arthritis J. Immunol., November 1, 2001; 167(9): 5381 - 5385. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhong, A. D. Roberts, and D. L. Woodland Antibody-Independent Antiviral Function of Memory CD4+ T Cells In Vivo Requires Regulatory Signals from CD8+ Effector T Cells J. Immunol., August 1, 2001; 167(3): 1379 - 1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Peters, H. M. Scott, H. F. Chambers, J. L. Flynn, I. F. Charo, and J. D. Ernst Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis PNAS, July 3, 2001; 98(14): 7958 - 7963. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cerdan, E. Devilard, L. Xerri, and D. Olive The C-class chemokine lymphotactin costimulates the apoptosis of human CD4+ T cells Blood, April 15, 2001; 97(8): 2205 - 2212. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Buri, M. Korner, P. Scharli, D. Cefai, M. Uguccioni, C. Mueller, J. A. Laissue, and L. Mazzucchelli CC chemokines and the receptors CCR3 and CCR5 are differentially expressed in the nonneoplastic leukocytic infiltrates of Hodgkin disease Blood, March 15, 2001; 97(6): 1543 - 1548. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Chensue, N. W. Lukacs, T.-Y. Yang, X. Shang, K. A. Frait, S. L. Kunkel, T. Kung, M. T. Wiekowski, J. A. Hedrick, D. N. Cook, et al. Aberrant In Vivo T Helper Type 2 Cell Response and Impaired Eosinophil Recruitment in CC Chemokine Receptor 8 Knockout Mice J. Exp. Med., February 26, 2001; 193(5): 573 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Till, L. A. Jopling, P. A. Wachholz, R. L. Robson, S. Qin, D. P. Andrew, L. Wu, J. van Neerven, T. J. Williams, S. R. Durham, et al. T Cell Phenotypes of the Normal Nasal Mucosa: Induction of Th2 Cytokines and CCR3 Expression by IL-4 J. Immunol., February 15, 2001; 166(4): 2303 - 2310. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Wiley, K. Palmer, B. U. Gajewska, M. R. Stampfli, D. Alvarez, A. J. Coyle, J.-C. Gutierrez-Ramos, and M. Jordana Expression of the Th1 Chemokine IFN-{{gamma}}-Inducible Protein 10 in the Airway Alters Mucosal Allergic Sensitization in Mice J. Immunol., February 15, 2001; 166(4): 2750 - 2759. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Andrew, N. Ruffing, C. H. Kim, W. Miao, H. Heath, Y. Li, K. Murphy, J. J. Campbell, E. C. Butcher, and L. Wu C-C Chemokine Receptor 4 Expression Defines a Major Subset of Circulating Nonintestinal Memory T Cells of Both Th1 and Th2 Potential J. Immunol., January 1, 2001; 166(1): 103 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Lillard Jr., P. N. Boyaka, D. D. Taub, and J. R. McGhee RANTES Potentiates Antigen-Specific Mucosal Immune Responses J. Immunol., January 1, 2001; 166(1): 162 - 169. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Peters, M. Dupuis, and I. F. Charo A Mechanism for the Impaired IFN-{gamma} Production in C-C Chemokine Receptor 2 (CCR2) Knockout Mice: Role of CCR2 in Linking the Innate and Adaptive Immune Responses J. Immunol., December 15, 2000; 165(12): 7072 - 7077. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-I. Sin, J. J. Kim, C. Pachuk, C. Satishchandran, and D. B. Weiner DNA Vaccines Encoding Interleukin-8 and RANTES Enhance Antigen-Specific Th1-Type CD4+ T-Cell-Mediated Protective Immunity against Herpes Simplex Virus Type 2 In Vivo J. Virol., December 1, 2000; 74(23): 11173 - 11180. [Abstract] [Full Text] |
||||
![]() |
X. Shang, B. Qiu, K. A. Frait, J. S. Hu, J. Sonstein, J. L. Curtis, B. Lu, C. Gerard, and S. W. Chensue Chemokine Receptor 1 Knockout Abrogates Natural Killer Cell Recruitment and Impairs Type-1 Cytokines in Lymphoid Tissue during Pulmonary Granuloma Formation Am. J. Pathol., December 1, 2000; 157(6): 2055 - 2063. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Izikson, R. S. Klein, I. F. Charo, H. L. Weiner, and A. D. Luster Resistance to Experimental Autoimmune Encephalomyelitis in Mice Lacking the CC Chemokine Receptor (CCR)2 J. Exp. Med., October 2, 2000; 192(7): 1075 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cerdan, E. Serfling, and D. Olive The C-class chemokine, lymphotactin, impairs the induction of Th1-type lymphokines in human CD4+ T cells Blood, July 15, 2000; 96(2): 420 - 428. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Andres, P. L. Beck, E. Mizoguchi, A. Mizoguchi, A. K. Bhan, T. Dawson, W. A. Kuziel, N. Maeda, R. P. MacDermott, D. K. Podolsky, et al. Mice with a Selective Deletion of the CC Chemokine Receptors 5 or 2 Are Protected from Dextran Sodium Sulfate-Mediated Colitis: Lack of CC Chemokine Receptor 5 Expression Results in a NK1.1+ Lymphocyte-Associated Th2-Type Immune Response in the Intestine J. Immunol., June 15, 2000; 164(12): 6303 - 6312. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nanki and P. E. Lipsky Cutting Edge: Stromal Cell-Derived Factor-1 Is a Costimulator for CD4+ T Cell Activation J. Immunol., May 15, 2000; 164(10): 5010 - 5014. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tani, W. J. Murphy, O. Chertov, R. Salcedo, C. Y. Koh, I. Utsunomiya, S. Funakoshi, O. Asai, S. H. Herrmann, J. M. Wang, et al. Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens Int. Immunol., May 1, 2000; 12(5): 691 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Lerner, M. R. Horton, R. H. Schwartz, and J. D. Powell Distinct Requirements for C-C Chemokine and IL-2 Production by Naive, Previously Activated, and Anergic T Cells J. Immunol., April 15, 2000; 164(8): 3996 - 4002. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kuroiwa, R. Schlimgen, G. G. Illei, I. B. McInnes, and D. T. Boumpas Distinct T Cell/Renal Tubular Epithelial Cell Interactions Define Differential Chemokine Production: Implications for Tubulointerstitial Injury in Chronic Glomerulonephritides J. Immunol., March 15, 2000; 164(6): 3323 - 3329. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Matsukawa, N. W. Lukacs, T. J. Standiford, S. W. Chensue, and S. L. Kunkel Adenoviral-Mediated Overexpression of Monocyte Chemoattractant Protein-1 Differentially Alters the Development of Th1 and Th2 Type Responses In Vivo J. Immunol., February 15, 2000; 164(4): 1699 - 1704. [Abstract] [Full Text] [PDF] |
||||
![]() |
G X Zhang, C M Baker, D L Kolson, and A M Rostami Chemokines and chemokine receptors in the pathogenesis of multiple sclerosis Multiple Sclerosis, February 1, 2000; 6(1): 3 - 13. [Abstract] [PDF] |
||||
![]() |
P. Andersen and B. Smedegaard CD4+ T-Cell Subsets That Mediate Immunological Memory to Mycobacterium tuberculosis Infection in Mice Infect. Immun., February 1, 2000; 68(2): 621 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. SEGERER, P. J. NELSON, and D. SCHLÖNDORFF Chemokines, Chemokine Receptors, and Renal Disease: From Basic ScienceTo Pathophysiologic and Therapeutic Studies J. Am. Soc. Nephrol., January 1, 2000; 11(1): 152 - 176. [Abstract] [Full Text] |
||||
![]() |
Philip. L. Shields, C. M. Morland, M. Salmon, S. Qin, S. G. Hubscher, and D. H. Adams Chemokine and Chemokine Receptor Interactions Provide a Mechanism for Selective T Cell Recruitment to Specific Liver Compartments Within Hepatitis C-Infected Liver J. Immunol., December 1, 1999; 163(11): 6236 - 6243. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Zabel, W. W. Agace, J. J. Campbell, H. M. Heath, D. Parent, A. I. Roberts, E. C. Ebert, N. Kassam, S. Qin, M. Zovko, et al. Human G Protein-coupled Receptor GPR-9-6/CC Chemokine Receptor 9 Is Selectively Expressed on Intestinal Homing T Lymphocytes, Mucosal Lymphocytes, and Thymocytes and Is Required for Thymus-expressed Chemokine-mediated Chemotaxis J. Exp. Med., November 1, 1999; 190(9): 1241 - 1256. [Abstract] [Full Text] [PDF] |
||||